ACE and angioedema: Finally, while this study supports earlier findings of an increased risk of tPA-induced angioedema with ACE inhibitor use and suggests consideration should be taken on stopping the ACE inhibitor or withholding tPA, it more importantly shows that development of severe angioedema results in increased LOS without compromising overall survival, which has not been shown in previous studies.